Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 343, Issue 4, pp 384–392 | Cite as

Comparison of cromakalim-induced relaxation of potassium precontracted rabbit, cat, and rat isolated cerebral arteries

  • Andrew A. Parsons
  • Ernst Ksoll
  • Jan R. L. Mackert
  • Lothar Schilling
  • Michael Wahl
Article

Summary

The effects of cromakalim were investigated in KCl-precontracted cat, rabbit, and rat isolated cerebral arteries with intact endothelium. Potassium induced contraction of all cerebral arteries studied, but exhibited marked vessel and species variation with no spasm to 20 or 30 mmol/l KCl in the rat basilar artery or 20 mmol/l KCl in the rabbit middle cerebral artery. On sustained tension to 20 mmol/l KCl, cromakalim induced concentration-related relaxation in the rabbit basilar artery and the cat basilar and middle cerebral arteries with Hill coefficients greater than unity. Cromakalim was more potent in the rabbit basilar artery precontracted with 20 or 30 mmol/KCl than in the rabbit middle cerebral artery or the cat basilar or middle cerebral artery. Elevation of the KCl concentration to 50 mmol/l inhibited cromakalim-induced relaxation and produced a decrease in the Hill coefficient. Preincubation of cerebral arteries with glibenclamide (100 nmol/l–1 μmol/1) produced concentration-related inhibition of the cromakalim-induced relaxation in the rabbit basilar, cat basilar, and cat middle cerebral arteries precontracted with 20 mmol/l KCl. The degree of rightward shift of concentration-effect curves by glibenclamide was calculated at the EC25, EC50, and EC75 levels. A good correlation was observed between the shifts at the EC50 and EC50 levels. However, the shift in concentration — effect curves for cromakalim produced at the EC25 level was markedly less than the-EC50 or EC75 levels in the presence of 1 μmol/1 glibenclamide. The pA2 values for glibenclamide calculated at the EC50 level were 6.6 ± 0.09, 7.1 ± 0.1, and 6.5 ± 0.5 in the rabbit basilar, cat basilar, and cat middle cerebral artery, respectively. The slope of the Schild regression for the inhibitory effect of glibenclamide in the rabbit basilar artery was significantly greater than unity but did not differ from unity in cat cerebral arteries. Glibenclamide (1 μmol/l) produced a similar degree of inhibition of the cromakalim-induced relaxation in the 30 mmol/l KCl precontracted rabbit middle cerebral artery and in the rabbit basilar artery exposed to 20 mmol/l KCl. In contrast, tolbutamide 10 μmol/l was essentially inactive against the cromakalim-induced relaxation in all vessels studied. It is concluded that cromakalim produces concentration-dependent relaxations of rabbit and cat isolated cerebral arteries by a mechanism that is similar to that identified in peripheral vasculature and visceral smooth muscle. In this study we were unable to demonstrate effects of cromakalim on the KCl precontracted rat basilar artery, possibly due to the low sensitivity of this preparation to KCl.

Key words

Cromakalim Glibenclamide Cerebral arteries K+ channel opener Potassium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen SL, Boyle JP, Cortijo J, Foster RW, Morgan GP, Small RC (1986) Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. Br J Pharmacol 89:395–405CrossRefGoogle Scholar
  2. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58Google Scholar
  3. Baird A, Hamilton TC, Richards DH, Tasker T, Williams AJ (1988) Inhibition of histamine induced bronchoconstriction in normal healthy volunteers by a potassium channel activator. Br J Clin Pharmacol 25:114PGoogle Scholar
  4. Beech DJ, Bolton TB (1989) Properties of the cromakahm- induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein. Br J Pharmacol 98:851–864CrossRefGoogle Scholar
  5. Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond [B] 220:141–162CrossRefGoogle Scholar
  6. Bray KM, Newgreen DT, Small RC, Southerton JS, Taylor SG, Weir SW, Weston AH (1987) Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate. Br J Pharmacol 91:421–429CrossRefGoogle Scholar
  7. Bray KM, Weston AH, McHarg AD, Newgreen DT, Southerton JS, Duty S (1988) Further studies on the actions of the K-channel openers cromakalim (BRL34915) and pinacidil in rabbit aorta. Pfügers Arch 411:R202Google Scholar
  8. Buchheit KH, Bertholet A (1988) Inhibition of small intestine motility by cromakalim (BRL 34915). Eur J Pharmacol 154:335–337CrossRefGoogle Scholar
  9. Buckingham RE, Hamilton TC, Howelett DR, Mootoo S, Wilson C (1989) Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol 97:57–64CrossRefGoogle Scholar
  10. Cain CR, Nicholson CD (1989) Comparison of the effects of cromakalim, a potassium conductance enhancer, and nimodipine, a calcium antagonists, on 5-hydroxytryptamine responses in a variety of vascular smooth muscle preparations. Naunyn-Schmiedeberg's Arch Pharmacol 340:293–299CrossRefGoogle Scholar
  11. Cavero I, Mondot S, Mestre M (1989) Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther 248:1261–1268PubMedGoogle Scholar
  12. deWeille JR, Fosset M, Mourre C, Schmid-Antomarchi H, Bernardi H, Lazdunski M (1989) Pharmacology and regulation of ATP-sensitive K+ channels. Pflügers Arch 414, Suppl 1:S80-S87CrossRefGoogle Scholar
  13. Doggrell SA, Smith JW, Downing OA, Wilson KA (1989) Hyperpolarizing action of cromakalim on the rat aorta. Eur J Pharmacol 174:131–133CrossRefGoogle Scholar
  14. Dunne MJ, Aspinall RJ, Petersen OH (1990) The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells. Br J Pharmacol 99:169–175CrossRefGoogle Scholar
  15. Garland CJ (1987) The role of membrane depolarization in the contractile response to the rabbit basilar artery to 5-hydroxytryptamine. J Physiol (Lond) 392:333–348CrossRefGoogle Scholar
  16. Gelband CH, Lodge NJ, van Breemen C (1989) A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim. Eur J Pharmacol 167:201–210CrossRefGoogle Scholar
  17. Grant TL, O'Hara K (1989) Comparison of the effects of cromakalim (BRL34915) on rabbit isolated basilar artery and thoracic aorta. Br J Pharmacol Proc Suppl 98:721PGoogle Scholar
  18. Hamel E, Edvinsson L, MacKenzie ETE (1988) Heterogenous vasomotor responses of anatomically distinct feline cerebral arteries. Br J Pharmacol 94:423–436CrossRefGoogle Scholar
  19. Hamilton TC, Weston AH (1989) Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol 20:1–9CrossRefGoogle Scholar
  20. Hamilton TC, Weir SW, Weston AH (1986) Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 88:103–111CrossRefGoogle Scholar
  21. Harder DR (1980) Comparison of electrical properties of middle cerebral and mesenteric artery in cat. Am J Physiol 239:C23-C26CrossRefGoogle Scholar
  22. Harder DR (1982) Effect of H+ and elevated P CO2 on membrane electrical properties of rat cerebral arteries. Pfügers Arch 394:182–185CrossRefGoogle Scholar
  23. Harder DR, Waters A (1983) Electromechanical coupling in feline basilar artery in response to serotonin. Eur J Pharmacol 93:95–100CrossRefGoogle Scholar
  24. Harder DR, Dernbach P, Waters A (1987) Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 80:875–880CrossRefGoogle Scholar
  25. Högestätt ED, Andersson K-E, Edvinsson L (1983) Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49–61CrossRefGoogle Scholar
  26. Hollingsworth M, Amedee T, Edwards D, Mironneau J, Savineau JP, Small RC, Weston AH (1987) The relaxant action of BRL 34915 in rat uterus. Br J Pharmacol 91:803–813CrossRefGoogle Scholar
  27. Kenakin TP (1984) The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev 36:165–222PubMedGoogle Scholar
  28. Ksoll E, Parsons AA, Mackert JRL, Schilling L, Wahl M (1991) Analysis of cromakalim-, pinacidil- and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol (in press)Google Scholar
  29. Kuschinsky W, Wahl M, Bosse O, Thurau K (1972) Perivascular potassium and pH as determinents of local pial arterial diameter in cats. Circ Res 31:240–247CrossRefGoogle Scholar
  30. Mackay D (1990) Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex models. Trends Pharmacol Sci 11:17–22CrossRefGoogle Scholar
  31. Parsons AA, Whalley ET (1989) Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries. Eur J Pharmacol 174:189–196CrossRefGoogle Scholar
  32. Parsons AA, Ksoll E, Mackert JRL, Schilling L, Wahl M (1990) Effect of sulfonylureas on cromakalim induced relaxation of KCl precontracted rabbit, cat and rat isolated cerebral arteries. Br J Pharmacol Proc Suppl 100:457Google Scholar
  33. Quast U (1987) Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein. Br J Pharmacol 91:569–578CrossRefGoogle Scholar
  34. Quast U, Cook NS (1989) In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther 250:261–271PubMedGoogle Scholar
  35. Quast U, Scholtysik G, Weir SW, Cook NS (1988) Pertussis toxin treatment does not inhibit the effects of the potassium channel opener BRL34915 on rat isolated vascular and cardiac tissues. Naunyn-Schmiedeberg's Arch Pharmacol 337:98–104CrossRefGoogle Scholar
  36. Rang HP (1971) Drug receptors and their function. Nature 231:91–96CrossRefGoogle Scholar
  37. Sato M (1989) GTP-binding proteins and their regulatory actions on ion channels. Jpn J Physiol 39:461–474CrossRefGoogle Scholar
  38. Schilling L, Wahl M (1989) Cerebrovascular effects of nimodipine in cats. Miner Electrolyte Metab 15:178–184PubMedGoogle Scholar
  39. Schmid-Antomarchi H, deWeille JR, Fosset M, Lazdunski M (1987) The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. J Biol Chem 262:15840–15844PubMedGoogle Scholar
  40. Southerton JS, Weston AH, Bray K, Newgreen DT, Taylor SG (1988) The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. Naunyn-Schmiedeberg's Arch Pharmacol 338:310–318CrossRefGoogle Scholar
  41. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT (1989) Hyperpolarising vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 245:177–180CrossRefGoogle Scholar
  42. Sumimoto K, Domae M, Yamanaka K, Nakao K, Hashimoto T, Kitamura K, Kuriyama H (1987) Actions of nicorandil on vascular smooth muscle. J Cardiovasc Pharmacol 10 Suppl 8:S66-S75CrossRefGoogle Scholar
  43. Taylor SG, Southerton JS, Weston AH, Baker JRJ (1988) Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim. Br J Pharmacol 94:853–863CrossRefGoogle Scholar
  44. Toda N (1974) Responsiveness to potassium and calcium ions of isolated cerebral arteries. Am J Physiol 227:1206–1211CrossRefGoogle Scholar
  45. Toda N, Nakajima S, Miyazaki M, Ueda M (1985) Vasodilatation induced by pinacidil in dogs. Comparison with hydralazine and nifedipine. J Cardiovasc Pharmacol 7:1118–1126CrossRefGoogle Scholar
  46. Trube G, Rorsman P, Ohno-Shosaku T (1986) Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic β-cells. Pflügers Arch 407:493–499CrossRefGoogle Scholar
  47. van Rossum JM (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299–330Google Scholar
  48. Wahl M (1985) Local chemical, neural and humoral regulation of cerebrovascular resistance vessels. J Cardiovasc Pharmacol 7 Suppl 8:S36-S46CrossRefGoogle Scholar
  49. Wahl M (1989) The effects of pinacidil and tolbutamide in feline pial arteries in situ. Pflügers Arch 415:250–252CrossRefGoogle Scholar
  50. Waters A, Harder DR (1985) Altered membrane properties of cerebral vascular smooth muscle following subarachnoid hemorrhage — an electrophysiological study: I. Changes in resting membrane potential (E m) and effect on the electrogenic pump potential contribution to E m. Stroke 16:990–997CrossRefGoogle Scholar
  51. Weir SW, Weston AH (1986a) Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci. Br J Pharmacol 88:113–120CrossRefGoogle Scholar
  52. Weir SW, Weston AH (1986b) The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol 88:121–128CrossRefGoogle Scholar
  53. Weston AH (1989) Smooth muscle K+ channel openers; their pharmacology and clinical potential. Pfügers Arch 414 Suppl 1:S99-S105CrossRefGoogle Scholar
  54. Whalley ET, Schilling L, Wahl M (1989) Cerebrovascular effects of prostanoids: in-vitro studies in feline middle cerebral and basilar artery. Prostaglandins 38:625–634CrossRefGoogle Scholar
  55. Wilson C (1989) Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro. J Autonom Pharmacol 9:71–78CrossRefGoogle Scholar
  56. Wilson C, Cooper SM (1989) Effect of cromakalim on contractions in rabbit isolated renal artery in the presence and absence of extracellular Ca2+. Br J Pharmacol 98:1303–1311CrossRefGoogle Scholar
  57. Winquist RJ, Heaney LA, Wallace AA, Baskin EP, Stein RB, Garcia ML, Kaczorowski GJ (1989) Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther 248:149–156PubMedGoogle Scholar
  58. Young AR, Pickard JD (1989) Potassium channel promoters and cerebrovascular smooth muscle contraction in vitro. J Cereb Blood Flow Metab 9 Suppl 1:S465Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Andrew A. Parsons
    • 1
  • Ernst Ksoll
    • 1
  • Jan R. L. Mackert
    • 1
  • Lothar Schilling
    • 1
  • Michael Wahl
    • 1
  1. 1.Physiologisches InstitutUniversität MünchenMünchen 2Germany

Personalised recommendations